Topics

Valence Advises INEOS on Acquisition of N.A. TiO2 Business from Tronox

08:12 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
The Valence Group acted as financial advisor to INEOS Enterprises, a division of INEOS, on its announced $700 million acquisition of Cristal’s North American titanium dioxide business from Tronox. The acquired business compris...

Other Sources for this Article

The Valence Group
Paul Lakind, 212-847-7339
plakind@valencegroup.com

NEXT ARTICLE

More From BioPortfolio on "Valence Advises INEOS on Acquisition of N.A. TiO2 Business from Tronox"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...